Latest Administration News

Investor Centre Limited is advancing key capital raising negotiations while its subsidiary Pulse Markets grows its wholesale trading business, positioning the company for operational expansion in 2025.

EverGreen Lithium’s 2024 drilling at the Bynoe Project confirms anomalous gold mineralisation but no significant lithium, prompting a strategic pivot to expanded gold and pegmatite exploration in 2025.

TZ Limited reported a challenging Q3 FY2025 with a $1.03 million net cash outflow amid US tariff disruptions but strengthened its SaaS base through the Keyvision acquisition, positioning for a rebound and growth in FY2026.

Energy World Corporation has appointed a global investment bank to spearhead funding efforts for its LNG and power projects in the Philippines, while reporting a $3.62 million operating cash outflow and the resignation of a senior executive.

Eden Innovations reports robust growth in EdenCrete®Pz7 sales, driven by expanded orders from Holcim Ecuador and the USA, alongside strategic US property sales aimed at debt reduction and operational efficiency.

Peninsula Energy has postponed commissioning of its Lance Uranium Project’s Central Processing Plant to the June quarter, prompting a downward revision of production forecasts through 2027 amid leadership changes and share suspension.

Peninsula Energy reported a $1.9 million operating cash outflow and $18.9 million investing spend on its Lance Project for Q1 2025, ending the quarter with $24.2 million in cash and an estimated 13 quarters of funding runway based on current outflows.

Talga Group advances its European battery materials ambitions with EU Strategic Project recognitions for its graphite mine and anode refinery, alongside a €70 million Innovation Fund grant.

CAQ Holdings Limited posted a 5% decline in leasing revenue for the March 2025 quarter, while vacancy rates held steady and operating cash flow remained positive despite ongoing regulatory uncertainties in China.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.

McLaren Minerals Limited reported a challenging quarter with operating and investing cash outflows offset by a significant equity financing inflow, ending March 2025 with a modest cash balance and less than two quarters of funding runway.